MOCERTATUG REZETECAN
UNII 7K6VKK6DP4

Substance Identification & Data

This profile provides standardized clinical and technical data for Mocertatug Rezetecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7K6VKK6DP4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3042848-25-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
7K6VKK6DP4
CAS Registry Number
3042848-25-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
MOCERTATUG REZETECAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C210991
National Cancer Institute reference terminology for clinical and research data.
INN ID
13782
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mocertatug Rezetecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MOCERTATUG REZETECAN

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN B7 HOMOLOG PROTEIN B7H4) (HUMAN-MUS MUSCULUS MONOCLONAL GSK5730912 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GSK5730912 .KAPPA.-CHAIN, DIMER, REDUCED, 214'',223,229,229',232,232'-HEXAKIS(THIOETHER) WITH N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)GLYCYLGLYCYL-L-PHENYLALANYL-N-(((1R)-1-CYCLOPROPYL-2-(((1S,9S)-9-ETHYL-5-FLUORO-2,3,9,10,13,15-HEXAHYDRO-9-HYDROXY-4-METHYL-10,13-DIOXO-1H,12H-BENZO(DE)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-1-YL)AMINO)-2-OXOETHOXY)METHYL)GLYCINAMIDE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS VTCN1 (V-SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1, B7 FAMILY MEMBER H4, B7H4, B7-H4)), HUMANIZED MONOCLONAL ANTIBODY; CONJUGATED ON AN AVERAGE OF SIX CYSTEINYL RESIDUES TO REZETECAN, COMPRISING A LINKER AND A CAMPTOTHECIN DERIVATIVE (EXATECAN)
MOCERTATUG REZETECAN [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus